Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determinants of Body Composition at Discharge and Fat-Free Mass as an Indicator of Neurological Development at 2 Years in Very Preterm Infants : OPTIPREMA Study

NCT02686801 is registered in ClinicalTrials.gov with Hôpital de la Croix-Rousse as lead sponsor.

NCT NCT02686801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02686801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determinants of Body Composition at Discharge and Fat-Free Mass as an Indicator of Neurological Development at 2 Years in Very Preterm Infants : OPTIPREMA Study
Lead sponsor
Hôpital de la Croix-Rousse
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2014
Completion date
December 31, 2019
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premature birth of newborn